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Problem 
Early/precocious puberty, while a relatively rare condition, occurs in approximately 20 
per 10,000 girls. Girls outnumber boys in precocious puberty by a three to one ratio (Steelman, 
2011). Approximately 4-5% of girls will go through precocious puberty (Shapiro, 2013). 
Early/precocious puberty can present with either signs of adrenarche (increased hormones in the 
body), thelarche (breast development, most common first sign), pubarche (appearance of pubic 
hair), or menarche (menstruation). With early pubertal timing girls have an increased risk of 
being treated differently by adults, with expectations to behave at the age of their outward 
appearance instead of their chronological age. Early pubertal timing increases the female’s risk 
of sexual abuse, obesity, cardiovascular disease, short adult stature, behavioral problems, breast 
cancer due to longer estrogen exposure over their lifetime, and risk taking behaviors such as 
alcohol and drug abuse as well as teen pregnancy.  
The ages to define the onset of puberty, precocious puberty, and early puberty are 
debatable within the medical community. The average age of puberty in girls is 10 to 14 years 
old (MedLinePlus, 2013). Precocious puberty is defined as the onset of secondary sexual 
characteristics before age 7/8 years in Caucasian girls and 6 years old in African American girls 
(Mayo Clinic, 2013). Additionally, menarche before 9 years old is indicative of precocious 
puberty (Mercola, 2012). Early puberty would be characterized as secondary sexual 
characteristics between 8 and 10 years old, although some define early puberty as less than 12 
years for research purposes. It is more commonly found in girls, with African American girls 
maturing on average one year earlier than their Caucasian/Hispanic counterparts.  
The pituitary gland, which regulates hormonal production and ovarian stimulation, starts 
producing hormones early leading to the development of secondary sexual characteristics 
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(University of Michigan Health System, 2013). For girls, the increase in estrogen levels 
stimulates breast enlargement (Tanner stage 2) in girls and is usually the first sign of puberty. 
However, in some cases menarche (menses) or pubarche (pubic hair) can appear first. 
Additionally, there is an increase in skeletal maturation, leading to an initial early height 
increase. However, final height in early/precocious puberty girls is usually less than their on-
time/late puberty counterparts (Shapiro, 2013). 
Precocious puberty can be divided into the following: central precocious puberty, or 
gonadotropin dependent (usually idiopathic) and peripheral precocious puberty, or gonadotropin 
independent (caused by increased estrogen in the body). GnRH testing can help distinguish 
between the two. Central precocious puberty, or idiopathic precocious puberty, is the most 
common. It is caused by early maturation of the Hypothalamus-Pituitary-Gonadal (HPG) axis. 
For central-type puberty to occur, there must be a functioning GnRH neuronal network and 
pulsatile GnRH secretions, caused by tonic inhibitory restraints (GABA receptors) and excitatory 
inputs (amino acid glutamate) to the GnRH neurons. The GnRH secretion mechanisms are 
located within the neuronal and glial networks (Partsch & Sippell, 2001). With HPG, the 
hypothalamus releases gonadotropin-releasing hormone (GnRH), which stimulates the anterior 
pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These 
hormones cause the ovaries to produce estrogen, which influences the development of secondary 
sexual characteristics. Although there is usually no identifiable cause in 69% to 98% of girls with 
central precocious puberty it may be caused by the following: tumor in the brain/spinal cord, 
defect at birth such as hydrocephalus or hamartoma (noncancerous tumor), radiation or injury to 
the spinal cord, McCune-Albright syndrome, congenital adrenal hyperplasia, or hypothyroidism 
(Mayo Clinic, 2013).  
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Peripheral precocious pubertal development is due to premature excretion of sex steroids 
from the ovaries, adrenal glands, pituitary, or exogenous exposure. This type of pubertal 
development originates peripherally, not centrally at the GnRH pulse generator, and will have 
low responses to GnRH stimulation (Partsch & Sippell, 2001). Additionally, the following may 
lead to precocious puberty: estrogen-secreting tumor of the adrenal glands or pituitary gland, 
McCune-Albright syndrome, and exposure to external sources of estrogen such as 
lotions/creams/ointments (Mayo Clinic, 2013).  
Possible causes of early or precocious puberty can include problems with the adrenal 
gland or ovaries. While there is debate among the medical community on when to test and treat 
for early/precocious puberty, providers must contemplate ruling out possible causes for early 
pubertal onset by evaluating for tumors and endocrine disorders (diabetes, polycystic ovarian 
syndrome, etc.). Obesity, environmental hazards, and social factors can increase the risk of early 
puberty (University of Michigan Health System, 2013). This article will review the literature for 
early and precocious (both central and peripheral) pubertal onset in girls less than 12 years old to 
achieve a better understanding of potential causes, patient impact, and management options. 
The Transactional Model of Stress and Coping, by Lazarus and Folkman (1984), views 
stress as an interaction between people and their external environment. It interprets stress as a 
stressor only if the person perceives it as such. However, if perceived as harmless, or even a 
challenge, then the stress is not viewed as a stressor and may even be viewed as a positive. 
Additionally, the coping resources the person utilizes can diminish their perception of stress as a 
stressor. With adequate coping skills, people can change their viewpoints of stressors and 
actually thrive on life’s challenges.  
The Transactional Model of Stress and Coping will be examined for girls diagnosed with 
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early/precocious puberty. This model looks at the diagnosis (early/precocious puberty), the 
appraisal of the situation (personality factors, social support, coping skills) that interacts with 
stressors (immunologic/neuroendocrine function), which determine the health outcomes. Within 
this study, the diagnosis is early/precocious puberty. The appraisal of the situation involves the 
child’s social support network (friends/family), their personality factors (are they anxious 
children regularly) and their coping skills (how well are they able to cope with breast 
development, pubic hair growth, physician appointments, treatments, etc.). These factors interact 
with the endocrinology/pathophysiology of their condition (hyperinsulinemia, hypothyroidism, 
etc.) to produce a positive health outcome (healthy status, treatment decisions, mood, 
anxiety/depression/etc.). The goal for the early/precocious puberty child would be having a 
supportive system, an adaptive personality, and well developed coping skills to achieve a healthy 
outcome in regards to decision making, mood, and optimal health status (Lazarus & Folkman, 
1984).  
Literature Review 
Research databases Cinhal, PubMed, Sage Premier, as well online journals (Pediatrics) 
and the American Academy of Pediatrics were searched for journal articles published within the 
last 15 years. Search terms included early puberty, precocious puberty, early menarche, sexual 
maturation, and secondary sex characteristics. The search included articles that contained the 
proposed cause of early/precocious puberty, its impact on girls, and the recommended treatment 
options. 
Causes of Early/Precocious Puberty 
Stress. Frigon & Trembaly (2005) examined the stress levels of young girls, their family 
life, and the onset of puberty in relation to behavioral outcomes. They found that the girls who 
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reported more anxiety at 8 years old had an increased risk of early menses (P=0.01). 
Consequently, the girls who entered puberty earlier than their peers reported less sleep 
(P=0.002), more externalized problem behaviors (P=0.02), and increased difficulty relating to 
their parents and peers (P=0.01).  
Abuse. Wise, Palmer, Rothman, & Rosenberg (2009) conducted a retrospective of study 
black women that examined childhood physical/sexual abuse and age of menarche. After 
adjusted analyses, they found that participants who reported sexual abuse in childhood also 
reported earlier menarche. Physical abuse had a weak but still statistically significant link with 
early menarche. Women who reported any childhood abuse were 1.12 times more likely to report 
early menarche compared to those women who reported no abuse in childhood (95%CI=1.08, 
1.16). Physical abuse only victims were 1.05 times more likely to report early menarche 
(95%CI=1.01, 1.09). Sexual abuse only victims were 1.27 times more likely (95%CI=1.20, 1.35) 
and physical and sexual abuse victims were 1.22 more likely (95%CI=1.16, 1.28) to report early 
menarche. Additionally, the more childhood incidences of abuse reported further increased the 
risk of early menarche: number of sexual abuse incidents of one to three (1.26, 95%CI=1.18, 
1.34) and four or more (1.34, 95%CI=1.23, 1.45).  
Obesity. Davison, Susman, & Birch (2003) conducted a longitudinal study of 183 white 
girls ranging from 5 to 9 years old to determine if a causal relationship existed between weight 
status and pubertal timing. Their results indicated that girls at 5 years of age who had a higher 
percent body fat (p<0.01), and girls who were 7 years old with either a higher percent body fat, a 
higher BMI, or a larger waist circumference were more at risk of undergoing earlier sexual 
development at 9 years old (p<0.001). Approximately 59% of overweight girls at 9 years old 
showed early pubertal development. Additionally, girls with earlier puberty exhibited higher 
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estradiol levels. This study may indicate that weight status precedes puberty.  
Boynton-Jarrett et al. (2011) studied 32,218 mother-daughter dyads, looking at the 
correlation between gestational weight gain (GWG) and daughter’s age at menarche. They 
showed that mothers who reported a GWG of <10 lbs. or >40 lbs. were 30% more likely to have 
daughters with early onset menarche based on adjusted logistic regression models (P=0.0059). 
Additionally, GWG by the mother could influence the fetus’ metabolism resulting in increased 
risk of childhood obesity and hyperinsulinemia, which might affect pubertal onset.  
Anderson, Dallal, & Must (2003) compared data from two national surveys conducted 25 
years apart to examine the possible relationship between weight and race’s possible impact on 
the average age of menarche. They found that the average age of menarche dropped by 
approximately 2 ½ months, from 12.75 to 12.54 years, and the percentage of girls aged 10 to 15 
years old whose BMI was above the 95
th
 percentile increased from 16% to 27% (p<.0001). The 
findings seem to indicate that a higher relative weight is inversely correlated with an onset of 
early menarche, after controlling for age and race.  
Rosenfield, Lipton, & Drum (2009) took the data from the NHANES III (1988-1994) for 
children aged 8 through 18 years of age. Data was taken from the NHANES III survey of the US 
population from 1988 to 1994 of children aged 8 through 18 years old. Pubertal stages were 
estimated at 5%, 50%, and 95% of attainment. They found that girls with excessive BMI showed 
significantly higher breast appearance prevalence from ages 8.0 to 9.6 years (OR: 3.86 and 2.02, 
respectively) and pubarche from ages 8.0 through 10.2 years old (OR: 4.50 and 1.87, 
respectively) than the control group.  
Environmental Toxins. Environmental toxins are thought to be factors in the 
development of early/precocious puberty. The Federal Drug Administration (FDA) currently 
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allows the use of six hormones in the food supply including many sex hormones: estradiol, 
estriol, testosterone, and progesterone. Estrogen storage in fat tissue increases the risk of 
overweight children. Additionally, parabens, a known toxin, are found in everyday household 
items including soap, cosmetics, cleaning products, etc. The xenoestrogens mimic estrogen in the 
body (Landa, 2012).  
Buttke, Sircar, & Martin (2012) studied the association between the exposure of 
endocrine-disrupting hormones (EDC) and the age of menarche for girls aged 12 to 16 years old. 
They found that 2,5-dichlorophenol (2,5-DCP) alone and in combination with 2,4-
dichlorophenol (2,4 DCP) act as potential EDC’s and were inversely associated with an earlier 
age of menarche (hazard ratios of 1.10; 95% CI: 1.01, 1.10 and 1.09; 95% CI 1.01, 1.19, 
respectively; P=0.025). The phenol 2,5-DCP is a fumigant that is found in common household 
items such as mothballs, insect repellants, deodorizers, and toilet disinfectants.  
Boas et al. (2010) looked at urinary concentrations of twelve phthalate metabolites in 
relation to serum levels of TSH, thyroid hormones, and IGF-1 in children ages 4 through 9 years 
old. All associations in girls between peripheral thyroid hormones and unadjusted phthalate 
metabolites were negative, reaching significance for total T3 with most phthalate metabolites, for 
free T3 with MEP (monoethyl phthalate) and DEHP, di (2-ethylhexyl) metabolites, and for total 
T4 with MEP (B=-5.19, p=0.013) and total phthalate score (B=-0.48, p=0.037). IGFBP-3 
showed a significantly negative association with DEHP and MCiOP (monooxoisononyl 
phthalate) metabolites (p<0.05). The results seem to indicate negative associations between 
urinary phthalate concentrations and thyroid hormones, IGF-I (insulin-like growth factor I), and 
growth in children.  
Lopez-Espinosa, Mondal, Armstrong, Bloom, & Fletcher (2012) looked at the 
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relationship between thyroid function and Perfluoroalkyl acids in children who lived in close 
proximity to a chemical plant (Teflon) and consumed contaminated drinking water. 
Perfluoroalkyl acids (PFAAs), including perfluorooactanoate (PFOA, also called C8), 
perfluorooctane sulfonate (PFOS), and perfluorononanoic acid (PFNA) were examined by serum 
concentrations from 2005 through 2006 in 10, 725 children ages 1-17 years of age. The results 
seem to indicate that serum measurements of PFOA concentrations are associated with thyroid 
disease (usually hypothyroidism); odds ratio for hypothyroidism was 1.54 [95% confidence 
interval (CI): 1.00, 2.37] and interquartile range (IQR) contrast of 13 to 68 ng/mL. 
In a study of lab mice, Markay, Luque, Munoz de Toro, Sonnenschein, & Soto (2001) 
examined the relationship between in utero exposure to low doses of bisphenol A (BPA) at 25 
and 250 μg/kg. Their mammary glands were assessed for signs of breast enlargement at 10 days, 
1 month, and 6 months of age. At 6 months of age the results of ductal and alveolar structures 
were significantly higher in both classes of BPA exposed mice compared to the control group. 
The mammary glands exhibited a 29% (P<0.01) and a 25% (P<0.05) breast enlargement in the 
ductal area; a 237% (P<0.05) and a 219% (P<0.05) increase in the terminal duct area; a 192% 
(P<0.05) and a 139% increase in the terminal end buds; and a 288% (P<0.01) and a 361% 
(P<0.01) increase in the alveolar buds area. The results from this study seem to indicate that 
lower than currently considered significant doses of BPA may lead to early breast enlargement, 
usually the first sign of puberty. 
Nutrition. Talpade (2008) looked at the relationship between nutritional intake and body 
imaging on sexual maturation differences between 7 and 10 year old Hispanic American (HA) 
and African American (AA) girls. The results indicated that AA girls with secondary sexual 
characteristics consumed a diet higher in lipids (p=.025) and saturated fats (p=.048). 
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Additionally, food consumption and race between the girls who experienced early sexual 
maturation (one minimum characteristic) found significant differences between the consumption 
of lipids  (p=.04) being higher among AA and calcium (p=.04) being higher among HA. Higher 
intakes of calcium among HA girls (p=.006) and lipids among AA girls (p=.049) showed 
significant associations with increased breast development.  
Vitamin Deficiency. Villamor, Martin, & Mora-Plazas (2011) followed 242 girls whose 
mean age was 8.8 ± 1.6 years for 2.5 years and studied their Vitamin D nutrition in relation to 
the timing of menarche. The results indicated that Vitamin D-deficient girls were 3.03 times 
more likely to reach menarche earlier than vitamin D-sufficient girls (95% CI: 1.58-5.83). After 
adjustments for age at baseline for BMI-for-age z-score (HR: 2.05, 95%CI: 1.03-4.07), the 
relationship was partially attenuated.  
Impact of Early/Precocious Puberty 
Endocrine. Midyett, Moore, & Jacobson (2003) studied precocious puberty in girls 
before age 8 years. Within the group, 12.3% of the patients ranging in age from 6 to 8 had 
pathologic processes related to their precocious puberty, such as insulin 
resistance/hyperinsulinemia, hypothyroidism, growth hormone deficiency, and congenital 
adrenal hyperplasia. Approximately 45% of the study population was obese and 81% had 
additional endocrine pathologies. Girls who exhibited two signs of puberty had the greatest 
percentage of obesity compared to those with only one sign of puberty (P=.024); more than two 
thirds of the girls who presented with two or more signs of puberty displayed a bone age  >3SD 
above the mean, indicating a risk for decreased final adult height. Girls with breast development 
as the only sign of puberty exhibited the same amount of risk to losing adult height as the girls 
who presented with two signs of puberty. The results seem to indicate that girls under 8 years of 
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age who present with two signs of precocious puberty should receive a referral to an 
endocrinologist and those with one sign of puberty should receive, at a minimum, a bone age 
assessment.   
Cardiovascular. Güven, Cinaz, & Bideci (2005) examined the relationship between 
premature adrenarche (PA) and artherogenesis (artherogenic index, AI) in girls (ages 5.4 to 8.6 
years old) with premature adrenarche. The bone age with PA positively correlated with AI 
(P<0.05). Higher bone ages (P<0.05), weight, body mass index (BMI), systolic, diastolic, and 
mean arterial blood pressures (MBP) were found in the girls with premature adrenarche 
compared to their age matched counterparts. Additionally, the mean total cholesterol (TC), low-
density lipoprotein-cholesterol (LDL-C), very low-density lipoprotein-cholesterol (VLDL-C), 
TC/high-density lipoprotein-cholesterol (P=0.011) and LDL-C/HDL-C ratio (P<0.05), and 
artherogenic index (P<0.05) were significantly higher in the premature adrenarche group. The 
results seem to indicate a correlation between premature adrenarche and increased cholesterol 
levels.   
Psychological. Precocious puberty can have profound effects on an adolescent’s 
psychological well-being. Liao, Missenden, Hallam, & Conway (2005) conducted a retrospective 
qualitative study of women ages 31 to 65 years who underwent puberty before the age of 7 years 
old and found two recurring themes: “on being different” (sub themed into “feeling different”, 
“feeling a freak”, and “remaining different”) and “the adult child” (sub themed into loss of 
childhood, blurring of boundaries between adult/child, and the sexual child). The adults reported 
feeling different based on how people treated them. They reported feeling like freaks because 
providers did not know how to stop their pubertal progression. They felt they remained different 
even when their peers started puberty because they knew they had started it earlier. On being the 
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adult child, the adults felt like they were treated like adults while they still retained the cognitive 
abilities of a child, thereby being robbed of a childhood. The blurring of adult/child boundaries 
was felt because “…other children are getting cuddled and talked about, and you feel like you’re 
not because you look older, but you’re not, you’re really young, the same as them.” The sexual 
child was described by one participant who recalled her mother had decided she had breast 
development due to fondling herself; whereas another participant was told by doctors that her 
early development was due to sexual abuse (there was none) which decreased her willingness to 
talk to health professionals  
Deardorff, Gonzales, Christopher, Roosa, & Millsap (2005) conducted a retrospective 
study of women ages 18 to 22 years who were from four major ethnic groups (non-Hispanic 
white, black, Latino, and Native American) and who experienced a pregnancy in their teens or 
early 20s. The study examined the relationship between the participant’s onset of first menarche, 
first sexual encounter, first alcohol use, and the age at first pregnancy. The participants sampled 
experienced menarche earlier than 11.94 years (with early menarche being defined as before age 
12). The earlier age of menarche correlated to earlier age at first alcohol use (β=.16; z=4.63), the 
age at first alcohol use directly and positively related to age at first sex (β=.40; z=11.14) which 
had a significant increase of earlier age at first pregnancy (β=.56; z=17.59). A second analysis 
showed that all paths were significant (at P<.001) for the following: menarche to alcohol use 
(β=.13; z=3.79); menarche to sex (β=.20; z=6.02); alcohol use to sex (β=.33; z=10.09); sex to 
pregnancy (β=.46; z=14.46). The results seem to indicate that early menarche has a direct 
correlation on early first sexual encounter, early alcohol use, and an increased risk of early 
pregnancy.  
Copeland, Shanahan, Miller, Costello, Angold, & Maughan (2010) studied the outcomes 
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of early puberty in females. The longitudinal study consisted of girls ages 9, 11, and 13 years old 
followed into adulthood. Their results showed that participants who reported early pubertal 
development also reported increased criminal problems (P=0.34), early sexual activities 
(P=0.11), and increased social (P=0.04) and psychiatric problems (P=0.04) during their 
adolescent years. The largest areas of concern were in substance abuse and conduct problems 
(odds ratios >3.0). These negative behaviors tapered off in adulthood and the girls reached the 
same level of negative behaviors as their on-time or late puberty peers.  
Deng, Tao, Wan, Hao, Su, & Cao (2011) studied young Chinese women in high school 
(grades 7, 8, 10, and 11) and college students (freshman and sophomore) who reported early, on-
time, and late onset of menarche. The results indicated increased psychopathologic emotional 
symptoms, behavioral symptoms (p=0.000), and social adaptation problems (p=0.001) for high 
school girls who reported early menarche (p=0.024). Additionally, the female college students 
exhibited decreased psychopathology symptoms as follows: emotional symptoms (p=0.006), 
behavioral symptoms (p=0.003), and social adaptation problems (p=0.000). The results indicated 
higher frequency of disorders, such as psychopathological, suicide, and self-harming appeared in 
the high school students who reported earlier menarche. 
Kim & Lee (2012) evaluated the patterns of behavior and social competency in 34 girls 
with precocious puberty. Height, body weight, BMI, and pubertal development were evaluated 
along with a child behavior questionnaire that was completed by the parents. Weight (p<0.001) 
and BMI (p=0.001), social competence (p=0.048), externalizing problems (p=0.029), total 
behavior problems (p=0.008), thought problems (0.010), and attention problems (0.047) were 
significantly higher in the precocious puberty group. The results seem to indicate a correlation 
between increased weight and early puberty increasing the risk of behavior and social problems.  
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Management Options For Gonadotropin-dependent Precocious Puberty 
Children with precocious puberty have increased estrogen levels, which produce initial 
early skeletal maturation and early epiphyseal plate closure that results in a decreased final adult 
height. Affected children will have an increased height in early childhood sooner than their on 
time/late puberty counterparts but will also stop skeletal maturation sooner. Oerter, Manasco, 
Barnes, Jones, Hill, & Cutler (1991) conducted a study of children diagnosed with precocious 
puberty who were medicated with deslorelin, a long-acting luteinizing hormone-releasing 
hormone (LHRH) agonist that was used in LHRH-dependent precocious puberty to examine its 
effectiveness in increasing final adult height among the participants. The National Institutes of 
Health initiated the treatment in 1979; the following results are from the first forty-four patients 
to have attained adult height from the long-term trial. LHRH decreases gonadotropin and sex 
steroid levels leading to increased final adult height. At the start of treatment, the children were 
7.1 ± 1.2 years old, had a mean delay of 3.1 ± 0.3 years between pubertal onset and treatment, 
and a mean bone age of 11.8 ± 1.5 years. The study group received daily injections of deslorelin 
for at least 4.1 ± 1.3 years, and had been discontinued from treatment for 2.4 years at the time of 
study. The final adult height averaged -1.1 SD compared to the normal populations adult height. 
The final adult height of the participants was significantly greater (-1.1 vs. -2.0 SD, P<0.01) than 
the pretreatment height, but also significantly less than the predicted height at end of treatment (-
1.1 vs. -0.5 SD, P<0.01) and the genetic height derived from the parent’s measurements (-1.1 vs. 
0.1 SD, P<0.01). The mean adult height for the girls was 157.0  ± 5.9 cm (-1.1 ± 1.0 SD). The 
mean proximate adult height was significantly greater than the mean pretreatment predicted 
height (-1.1 ± 1.3 SD vs.  -2.0 ± 1.3 SD, P<0.01), by 5.2  ± 8.4 cm for the girls. The most recent 
predicted height was less than the predicted height at the end of treatment by 2.2 ± 4.0 cm 
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(P<0.01). Proximate adult height inversely correlated with pretreatment bone age (r=-0.35, 
P=0.02). Additionally, basal luteinizing hormone levels (P<0.01), LHRH-stimulated LH levels 
(P<0.01), LHRH-stimulated FSH levels (P<0.01), and Estradiol levels (P<0.01) all showed 
decreased serum concentrations at the completion of treatment compared with pretreatment 
values. The results seem to indicate that while deslorelin decreased hormone levels and increased 
the pretreatment predicted height in the test subjects by an average of 5 cm, it did not restore 
them to their full genetic potential.  
Kauli, Galatzer, Kornreich, Lazar, Pertzelan, & Laron (1997) studied girls with central 
precocious puberty (CPP) to determine the benefit of medication therapy on final height (FHt) 
and target height (THt). Of the total population, 28 were untreated, 26 were treated with 
cyproterone acetate (CyA), and 48 were treated with GnRH analogue (GnRHA). Their height 
was compared to their respective target height. The results indicated that girls who received 
treatment with either medication reached THt above (CyA group: FHt 157.8 +/- 5.1, THt 156.8 
+/- 5.1cm; GnRHA group: 159.6 +/- 6.3, THt 157.7 +/- 5.7 cm) their non-treated counterparts 
(THt +/- 0.5 SD; FHt 160.2 +/- 7.1, THt 159.5 +/- 6.6cm).  
Conclusion 
Early and precocious puberty is an increasingly global problem. Research has been done 
in many areas showing correlations with overweight/obesity, nutritional/vitamin factors, 
environmental chemicals/toxins, to name just a few. Identifying the cause of early puberty is 
essential in preventing adverse psychosocial and health outcomes. Children with early and 
precocious puberty have an increased risk of short stature, endocrine disorders (diabetes), 
cardiovascular disease, behavioral problems, sexual abuse, increased alcohol abuse, increased 
risk of early sexual encounter (which increase risk of STDs and cervical cancer), and increased 
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risk of teenage pregnancy (increasing risk of low socioeconomic status).  
Diagnostic testing should be performed on girls who are less than 8 years old presenting 
with signs of puberty, or girls between 8 and 10 years old who are exhibiting pubertal 
development and have any of the following: rapid progression of puberty with a skeletal 
maturation bone age >2SD years ahead of their chronological age (diagnosed by x-ray of the 
wrist) with a predicted height >2SD (4 inches) below their genetic target height, central nervous 
system problems (seizures, hydrocephalus, etc.), or behavior problems associated with early 
physical maturation. Diagnostic testing includes differentiating between central and peripheral 
puberty. The provider should perform a thorough medical history and physical exam, order blood 
tests (thyroid profile, Vitamin D levels, hormone levels: LH, FSH, Estradiol), x-ray of hand (to 
determine bone age), and a GnRH stimulation test with blood sample (with central precocious 
puberty then the other hormone levels will rise, with peripheral precocious puberty the other 
hormone levels will remain the same). Tumors can be detected by a CT/MRI of the head and 
abdomen. Cysts can be detected by ultrasound. If a cause is identified then treating the 
cause/referral is the preferred method of choice. If bone scans indicate advanced bone age or the 
child exhibits decreased coping skills with the maturation, referral to a pediatric endocrinologist 
for further testing and treatment provides advanced care and possible relief of symptoms (Mayo 
Clinic, 2013). 
Treatment of precocious puberty can include treating the underlying disease if any is 
found, psychological therapy, and medication to delay further pubertal onset. The complications 
of precocious puberty can include psychological problems, short height, and increased risk of 
cardiovascular disease (Mayo Clinic, 2013).  The goal is to delay the onset of early puberty. This 
gives the child time to reach psychological maturing, decreases the risk of short height, and helps 
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decrease the risk of endocrine disorders (diabetes, PCOS) and cardiovascular disease.  
With the knowledge gained from research, the healthcare provider can increase his or her 
screening process by effectively evaluating, diagnosing, and hopefully preventing early or 
precocious puberty. Modifiable factors include encouraging parents to buy products without 
parabens, decrease stress in the home, eat a well balanced and nutritious diet, maintain a healthy 
weight, monitor/decrease risk of sexual abuse, avoid toxins that mimic estrogens, and encourage 
mothers to maintain a healthy weight during pregnancy to help prevent the risk of early or 
precocious puberty. Universities, healthcare centers, drug companies, the Federal Drug 
Administration, and the Environmental Protection Agency need to continue to expand and clarify 
their research. As early and precocious puberty looks to be a multifactorial problem, additional 
areas of research need to be completed to understand what else can increase the risk of early 
pubertal timing. With research findings politicians can then enact statutes and laws to protect 
young girls from potential hazards in food, household products, etc.  
Additional studies need to be conducted to determine more causes of precocious puberty. 
The earlier a cause is identified the earlier prevention and treatment can be implemented by 
patients and providers to halt early pubertal timing and decrease its complications. To date, while 
Canada and other countries have stopped using BPA in their products (a potential endocrine 
disruptor), thus limiting the American consumers exposure, the FDA has yet to ban it from the 
US market. The FDA needs to remove BPA and other known toxins from US products. 
In conclusion, the American Academy of Pediatrics and other pediatric and medical 
associations need more concise definitions and parameters implemented. Depending on what 
article is referenced, the age for early and precocious puberty can be evaluated at less than 6, 8, 
or 12 years. Also, agencies and physicians debate about the treatment options of precocious 
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puberty. While some providers may see precocious puberty as a benign condition, others believe 
the condition warrants further testing to make sure the early onset is not due to an endocrine 
disorder, tumor, or disease process. More stringent evaluating, diagnosing and managing 
guidelines from evidenced based practice would allow for better long term outcomes in young 
girls.  
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Author & Year Inclusion Criteria Type of Study/Treatment  Primary Outcomes /Conclusions 
Tremblay & Frigon. (2005). 
Precocious puberty in adolescent 
girls: A biomarker of later 
psychosocial adjustment 
problems. Child Psychiatry and 
Human Development, 36(1), 73-
94. Doi:10.1007/s10578-
00403489-2 
Parents of 1039 girls completed a 
questionnaire about theirs & the 
family’s characteristics. Followed 
children from 6 years old (non-
puberty) until 17 years of age.  
Representative sample of 3017 
children & their parents. 
Followed longitudinally from 
1986 (children 6 years old) until 
they were 17 years old. 
Completed questionnaire yearly 
evaluating anxiety, stress and 
pubertal development. 
Level 3 
The results indicated that girls 
who reported more anxiety at 8 
years old had an increased risk of 
early menses. Stress was 
measured two ways the first was 
the Family Adversity Index, 
which evaluated socioeconomic 
status, family structure, and 
parental occupation, with a 
distribution range from 0.00 
(favorable condition) to 1.00 
(higher level of adverse 
conditions); M=0.23, SD=0.23, 
and M=0.24, SD=0.24 at 6 and 8 
years old, respectively). Next, the 
Stressful Event Checklist, which 
attributed a 1-point score with a 0 
to 5 distribution range for 
divorce, separation, and disease 
of the child within the last 12 
months that was assessed 
between 6 and 7 and between 7 
and 8 years old; M=0.51, 
SD=0.84). Consequently, the 
girls who entered puberty earlier 
than their peers reported less 
sleep, more externalized problem 
behaviors, and increased 
difficulty relating to their parents 
and peers. 
Davison, Susman, & Birch. 
(2003). Percent body fat at age 5 
predicts earlier pubertal 
development among girls at age 
9. Pediatrics, 111(4), 815-821. 
181 girls age 5, 7, & 9 years old 
with puberty being assessed at 9 
years.  
  
Longitudinal correlational study 
examining relationship between 
nutrition, weight, BMI, and waist 
measurement on pubertal timing. 
Level 4 
Girls at 5 years of age who had a 
higher percent body fat; and girls 
who were 7 years old with a 
higher percent body fat, greater 
linear increase in percent body fat 
(OR=1.17; 95% CI=1.05-1.30), 
higher percentile BMI, larger 
waist circumference, or greater 
linear increase in weight 
circumference (OR=1.12; 95% 
CI=1.01-1.24) were more at risk 
of undergoing earlier sexual 
development at 9 years. The girls 
with earlier puberty exhibited 
higher estradiol levels. 
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Author & Year Inclusion Criteria Type of Study/Treatment Primary Outcomes/Conclusions 
Boynton-Jarrett, Rich-Edwards, 
Fredman, Hilbert, Michels, 
Forman, & Wright. (2011). 
Gestational weight gain and 
daughter’s age at menarche. 
Journal of Women’s Health, 
20(8), 1193-1200. 
Doi:10.1089/jwh.2010.2517 
32,218 mother/daughter dyads Prospective cohort study of 
mother/daughter dyads looking 
@ mothers gestational weight 
gain & daughter’s age of 
menarche. 
Level 4 
Mothers who had a  Gestational 
Weight Gain (GWG) of <10 lbs. 
or >40 lbs. were 30% more likely 
to have daughters with early 
onset menarche based on an 
adjusted logistic regression 
models (OR=1.31, 95% CI=1.05-
1.62, and OR=1.27, 95% 
CI=1.06-1.56; P=0.0059). 
Anderson, Dallal, & Must. 
(2003). Relative weight and race 
influence average age at 
menarche: Results from two 
nationally representative surveys 
of US girls studied 25 years 
apart. Pediatrics, 111(4), 844-
850. 
1109 girls ages 10+years and 
2218 girls ages 12-15 years old.  
National Health Examination 
Surveys cycles II & III (1963-
1970) compared with results from 
Third National Health and 
Nutrition Examination Survey 
(1988-1994) evaluating weight, 
BMI and age of menarche.  
Systematic review of 
correlational studies.  
Level 4 
The results indicated that the 
average age of menarche dropped 
approximately 2 ½ months on 
average, from 12.75 to 12.54 
years (NHES 95% CI: 12.69-
12.82 years compared to 
NHANES III 95% CI: 12.44-
12.64 years), and the percentage 
of girls aged 10 to 15 years old 
were above the 95th percentile for 
BMI increased from 16% to 27% 
(BMI z-score 0.93 units higher in 
NHES and 0.83 units higher; 
p<.0001 in independent sample t 
test in NHANES IIII than girls 
who had not reached menarche) 
over the 25 year time period. The 
higher relative weight was 
associated with the increased 
onset of early menarche, after 
controlling for age and race. 
Rosenfield, Lipton, & Drum. 
(2009). Thelarche, pubarche, and 
menarche attainment in children 
with normal and elevated body 
mass index. Pediatrics, 123(1), 
84-88. Doi:10.1542/peds.2008-
0146 
Children from the Third National 
Health and Nutrition 
Examination Survey and the 
NHANES III survey of the US 
population from 1988 to 1994 of 
children aged 8- through 18 years 
old. The data was extrapolated 
from girls with a normal BMI 
(control group) and those with 
excessive BMI (≥ 85th 
percentile). Pubertal stages were 
estimated at 5%, 50%, and 95% 
of attainment. 
 
Survey Sampling Design.  
Single observational study 
evaluating the relationship 
between BMI and pubertal 
development. 
Level 4 
The results concluded that girls 
with excessive BMI showed 
significantly higher breast 
appearance prevalence from ages 
8.0 to 9.6 years (OR: 3.86 and 
2.02, respectively) and pubarche 
from ages 8.0 through 10.2 years 
old (OR: 4.50 and 1.87, 
respectively) than the control 
group 
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Author & Year Inclusion Criteria Type of Study/Treatment Primary Outcomes/Conclusions 
Buttke, Sircar, & Martin. (2012). 
Exposures to endocrine-disrupting 
chemicals and age of menarche in 
adolescent girls in NHANES 
(2003-2008). Environmental 
Health Perspectives, 120(11), 
1613-1618.  
440 females age 12-16 years old (NHANES) Cross-sectional, 
multistage, stratified, cluster 
sampling survey conducted by 
the CDC looking at the 
relationship between potential 
EDC’s and menarche in females. 
Level 2 
2,5-DCP, a potential EDC, was 
inversely associated with the age 
of menarche in females (hazard 
ratios 1.10; CI 95%=1.01, 1.19, 
P=0.025). This is a fumigant that 
is also found in mothballs, insect 
repellants, deodorizers, and toilet 
disinfectants. 
Boas, Frederiksen, Feldt-
Rasmussen, Skakkebaek, 
Hegedüs, Hilsted, Juul, & Main. 
(2010). Childhood exposure to 
phthalates: Associations with 
thyroid function, insulin-like 
growth factor I, and growth. 
Environmental Health 
Perspectives, 118(10), 1458-
1464. Doi:10.1289.ehp.0901331 
845 children 4-9 years of age. 
Urinary concentrations of 12 
phthalate metabolites & serum 
levels of TSH, thyroid hormones, 
& IGF-I. 
Exclusions were children who 
suffered from diseases prone to 
affect growth or endocrine status 
as well as children with clinical 
signs of puberty. 
Children who had previously 
participated in a longitudinal 
cohort study, for which their 
mothers (1,953) during 
pregnancy were consecutively 
enrolled.  Study looked at urine 
phthalate concentrations and the 
hormone levels in children.  
Cohort study.  
Level 4 
The results indicated negative 
associations between urinary 
phthalate concentrations and 
thyroid hormones, IGF-1, and 
growth in children.  All 
association in girls between 
peripheral thyroid hormones and 
unadjusted phthalate metabolites 
were negative, reaching 
significance for total T3 with 
most phthalate metabolites, for 
free T3 with MEP and DEHP 
metabolites, and for total T4 with 
MEP (B=-5.19, p=0.013) and 
total phthalate score (B=-0.48, 
p=0.037). IGFBP-3 was 
significantly negatively 
associated wit DEHP metabolites 
and MCiOP (p<0.05). 
Lopez-Espinosa, Mondal, 
Armstrong, Bloom, & Fletcher. 
(2012). Thyroid function and 
perfluoroakyl acids in children 
living near a chemical plant. 
Environmental Health 
perspectives, 120(7), 1036-1041. 
10,725 children between 1-17 
years old that lived near Teflon 
chemical plant and had 
consumed local water for at least 
one year before 2004 
Convenience sampling of the 
population that met the inclusion 
criteria. Looked at the 
relationship between PFOA’s and 
thyroid disease. 
Level 4 
The study found that serum 
measurements of PFOA 
concentrations were positively 
associated with thyroid disease 
(usually hypothyroidism); odds 
ratio for hypothyroidism (n=39) 
was 1.54 [95% confidence 
interval (CI): 1.00, 2.37] for and 
interquartile range (IQR) contrast 
of 13 to 68 ng/mL 
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Author & Year Inclusion Criteria Type of Study/Treatment Primary Outcomes/Conclusions 
Markey, Luque, Munoz de Toro, 
Sonnenschein, & Soto,. (2001). In 
utero exposure to bisphenal a 
alters the development and tissue 
organization of the mouse 
mammary gland. Biology of 
Reproduction, 65(2001), 1215-
1223. 
Sexually mature, female CD-1 
mice (8 weeks of age).  
Clinical trial with control group.  
Single nonrandomized trial. Lab 
mice exposed to BPA in utero 
and then evaluated at different 
intervals for breast enlargement 
after birth. 
Level 2 
The researchers examined the 
relationship between in utero 
exposure to low doses of 
bisphenol A (BPA) at 25 and 250 
μg/kg of body and the amount of 
breast enlargement were assessed 
at 10 days, 1 month, and 6 
months of age. At 6 months of 
age the results of ductal and 
alveolar structures related to the 
control group were significant in 
both classes of BPA exposure. 
The mammary glands exhibited a 
29% (P<0.01) and a 25% 
(P<0.05) increase, respectively, 
in the ductal area; a 237% 
(P<0.05) and a 219% (P<0.05) 
increase in the terminal duct area; 
a 192% (P<0.05) and a 139% 
increase, respectively, in the 
terminal end buds; and a 288% 
(P<0.01) and a 361% (P<0.01) 
increase, respectively, in the 
alveolar buds area. Researchers 
considered the results significant 
at P<0.05. Even at lower than 
significant doses of BPA can lead 
to early breast enlargement, , 
which can also increase the risk 
of breast cancer throughout a 
females life.  
Talpade, M. (2008). Hispanic 
versus African American girls: 
Body image, nutrition, and 
puberty. Adolescence, 43(169), 
119-127. 
23 Hispanic Americans & 44 
African American girls ages 7-10 
years in pre-pubertal & early 
pubertal stages 
Pilot study. Convenience sample.  
The study looked at the 
relationship between nutrition 
and Hispanic and African 
American girl’s pubertal timing. 
Level 4 
The results indicated that AA 
girls with secondary sexual 
characteristics consumed higher 
intakes of Lipids, 
𝑥2(3,N=54)=9.337, p=.025 and 
saturated fats 𝑥2(3), 
N=54)=7.918, p=.048; 
additionally, the Mann-Whitney 
U test looked at food 
consumption and race between 
the girls who experienced early 
sexual maturation and found the 
consumption of lipids U 
(n=28)=36, p=.04; and calcium, 
U (n=28)=36, p=.04; among HA 
(n=7) versus AA girls (n-21) who 
presented with the presence of 
one sexual secondary 
characteristic. Finally, there was 
a significantly high intake of 
calcium among HA girls that 
associated with breast 
development, Mann Whitney 
U=12, n=6, p=.006 Mean 
Rank=18 for HA and Mean 
Rank=9) and a high intake of 
Lipids among AA girls, Mann 
Whitney U=21, n=16, p=.049 
(Mean Rank=1 for HA and Mean 
Rank=13). 
Villamor, E., Martin, C., & Mora-
Plazas, M. (2011). Vitamin d 
deficiency and age at menarche: 
A prospective study. American 
Journal of Clinical Nutrition, 
94:1020-1025. 
242 girls from the Bogota School 
Children Cohort. Ages ranged 
from 8.8 to +/- 1.6 years 
Prospective Study. Cohort. The 
study examined the relationship 
between Vitamin-D deficient and 
Vitamin-D sufficient girl’s and 
the timing of pubertal 
development. 
Level 4 
Vitamin D-deficient girls were 
3.03 (95% CI: 1.58-5.83) times 
more likely to reach menarche 
than vitamin D-sufficient girls. 
After adjustments for age at 
baseline for BMI-for-age z-score 
(HR: 2.05, 95%CI: 1.03-4.07)  
revealed attenuated results. 
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Author & Year Inclusion Criteria Type of Study/Treatment Primary Outcomes/Conclusions 
Midyett,J., Moore, W., & 
Jacobson, J. (2003). Are pubertal 
changes in girls before age 8 
benign? Pediatrics, 111(1), 47-51. 
1,570 girls referred for 
precocious puberty s/sx 
Retrospective chart review by a 
Pediatric Endocrinology clinic 
looking at girls referred for 
precocious puberty signs and 
their exam findings.  
Level 4 
Girls with two signs of puberty 
(thelarche, pubarche, or 
menarche) had greater obesity 
than those with one sign (p=0.24) 
& displayed a bone age >3SD 
above the mean. Girls with only 
breast development had the same 
risk to lose adult height as those 
with 2 signs of puberty. 
Kim, E.,  & Lee, M. (2012). 
Psychosocial aspects in girls with 
idiopathic precocious puberty. 
Psychiatric Investigation, 9(1), 
25-28. 
Doi:10.4306/pi.2012.9.1.25 
34 girls diagnosed with 
idiopathic precocious puberty 
who were patients in the 
Department of Pediatrics, 
Chosun University hospital from 
June 2010 to August 2010. 
Compared to 39 first year female 
studants in elementary school in 
Gwang-san gu with no evidence 
of pubertal development.  
Clinical group comparison study. 
Convenience sample.  Examined 
the relationship between weight 
and BMI on pubertal timing as 
well as the resulting psychosocial 
problems. 
Level 4 
The results indicated that weight 
(p<0.001) and BMI (p=0.001) 
were significantly higher in the 
precocious puberty group. 
Additionally, social competence 
(p=0.048), externalizing 
problems (p=0.029), total 
behavior problems (p=0.008), 
thought problems (0.010), and 
attention problems (0.047) were 
significantly higher in the 
precocious puberty group. The 
study shows a correlation 
between that weight impact 
puberty, and that early puberty 
increases behavior problems and 
social competencies. 
Güven, A., Cinaz, P., & Bidecii, 
A. (2005). Is premature 
adrenarche a risk factor for 
atherogenesis? Pediatric 
International, 47:20-25. 
24 prepubertal girls (age range, 
5.4-8.6 years) with 13 age 
matched controls (5.7-8.5 years). 
Cohort study. Study examined 
the relationship between Lipid 
values and premature adrenarche. 
Level 4 
Findings included TC/HDL-C 
(rho, -0.54; P, 0.011) and LDL-
C/HDL-C (rho, -0.0; P<0.05) and 
artherogenic index (AI; rho, -
0.43; P<0.05). Finally, the bone 
age with PA positively correlated 
with AI (rho, 0.456; P<0.05) The 
findings indicate higher bone 
age, weight, body mass index 
(BMI), systolic, diastolic, and 
mean arterial blood pressure 
(MBP) in the girls with 
premature adrenarche. 
Additionally, the mean total 
cholesterol (TC), low-density 
lipoprotein-cholesterol (LDL-C), 
very low-density lipoprotein-
cholesterol (VLDL-C), TC/high-
density lipoprotein-cholesterol 
(HDL-C) and LDL-C/HDL-C 
ratio, and artherogenic index 
were significantly higher in the 
premature adrenarche group as 
well.  
 
Liao, L., Missenden, K., Hallam, 
R.,  & Conway, G. (2005). 
Experience of early pubertal 
development: A preliminary 
analysis. Journal Of Reproductive 
and Infant Psychology, 23(3), 
219-233. 
Doi.10.1080/02646830500165804 
5 participants ages 31-65 years. 
Retrospective study. All had 
experienced pubertal 
development before 7 years old.  
Retrospective Single Qualitative 
study. Examined the subjective 
feelings/experiences of women 
who reported early/precocious 
puberty. 
Level 4 
2 themes found:  
“on-being different” & “the adult 
child” 
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Author & Year Inclusion Criteria Type of Study/Treatment Primary Outcomes 
Wise, L., Palmer, J., Rothman, E., & 
Rosenberg, L. (2009). Childhood 
abuse and early menarche: Findings 
from the black women’s health 
study. American Journal of Public 
Health, 99(S2), S460-S466. 
35,330 Black women Prospective cohort study. 
Regression data.  Studied the 
relationship between 
sexual/physical abuse and 
pubertal timing.  
Level 4 
After adjusted analyses, sexual 
abuse was positively correlated 
with early menarche, and 
physical abuse had a weak but 
statistically significant link with 
early menarche. Women who 
reported any abuse had 1.12 
times the risk of early menarche 
compared to those who reported 
no abuse (95%CI=1.08, 1.16). 
Physical abuse only were 1.05 
times more likely for early 
menarche (95%CI=1.01, 1.09), 
and 1.27 for sexual abuse only 
(95%CI=1.20, 1.35), and 1.22 
for physical and sexual abuse 
(95%CI=1.16, 1.28). 
Additionally, the increased 
number of sexual abuse 
incidents of 1 to 3 (1.26, 
95%CI=1.18, 1.34) and 4 or 
more (1.34, 95%CI=1.23, 1.45) 
increased the risk of early 
menarche 
Deardorff, J., Gonzales, N., 
Christopher, F., Roosa, M., & 
Millsap, R. (2005). Early puberty 
and adolescent pregnancy: The 
influence of alcohol use. Pediatrics, 
116(6), 1451-1456. 
Doi:10.1542/peds.2005-0542 
666 women ages 18 to 22 years 
who were either African 
American (N-92), non-Hispanic 
white (N=191), Latino 
(N=209), or Native American 
(159). Recruited at health 
clinics, shelters, colleges, & 
private providers).  
Convenience sampling of 
women who were in the target 
age range & had experienced a 
pregnancy in their teens or early 
20’s. 
Examined the relationship 
between early pubertal timing 
and alcohol abuse, first sexual 
encounters, and pregnancy.  
Level 4 
Experienced menarche lower 
than 11.94 years (with early 
menarche being defined as 
before age 12). Age at menarche 
related to both age at first 
alcohol use (β=.16; z=4.63). Age 
at first alcohol use directly and 
positively related to age at first 
sex (β=.40; z=11.14), which had 
a significant path to age at first 
pregnancy (β=.56; z=17.59) 
were also significant. The 
squared multiple correlation for 
age at first pregnancy (z=5.87) 
was .32, an indicator of the 
indirect effect between 
menarche and pregnancy (6.62). 
A second analysis showed that 
all paths were significant (at 
P<.001) for the following: 
menarche to alcohol use (β=.13; 
z=3.79); menarche to sex 
(β=.20; z=6.02); alcohol use to 
sex (β=.33; z=10.09).; sex to 
pregnancy (β=.46; z=14.46).  
Copeland, W., Shanahan, L., Miller, 
B., Costello, J., Angold, A.,  & 
Maughan, B. (2010). Outcomes of 
early pubertal timing in young 
women: A prospective population-
based study. The American Journal 
of Psychiatry, 167:1218-1225. 
Doi:10.1176/appl.ajp.2010.09081190 
 
 
 
 
 
 
 
1,420 children ages 9, 11, & 13 
followed into adulthood 
Longitudinal study with 3 
cohorts: ages 9, 11, & 13. 
Examined the relationship 
between early puberty and 
behavioral problems.  
Level 4 
Early puberty resulted in 
criminal problems (P=0.34); 
early sexual activities (P=0.11), 
social problems (P=0.04); and 
psychiatric problems (P=0.04) 
during the adolescent years. The 
biggest areas of concern were in 
substance abuse and conduct 
problems (odds ratios >3.0). 
Negative behaviors tapered off 
in adulthood and the girls 
reached the same level of 
negative behaviors as their on-
time or late puberty mature 
peers. 
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Deng, F., Tao, F., Wan, Y., Hao, J., 
Su, P., & Cao, Y. (2011). Early 
menarche and psychopathological 
symptoms in young Chinese women. 
Journal of Women’s Health, 20(2), 
207-213. 
Doi:10.1089/jwh.2010.2102 
5,597 high school students 
(grades 7, 8, & 11)& 2,768 
college students (freshman & 
sophomore). 
Stratified cluster sampling. 
Cohort study. Examined the 
relationship between early 
pubertal timing and 
psychopathological symptoms. 
Level 4 
The MSQA indicated 
psychopathology in emotional 
symptoms were 20.6%, 15.7%, 
and 16.9%, respectively, for the 
early, on-time, and late 
menarche groups (p=0.024); the 
percentages in behavioral 
symptoms were 27.7%, 19.3%, 
and 19.3%, respectively 
(p=0.000); the percentages in 
social adaptation problems were 
18.2%, 12.0%, and 12.7% 
respectively (p=0.001). For 
college students, the percentages 
of psychopathology in emotional 
symptoms were 17.3%, 9.4%, 
and 12.5%, respectively, for the 
early, on-time, and late 
menarche groups (p=0.006); the 
percentages in behavioral 
symptoms were 18.2%, 9.8%, 
and 13.3%, respectively 
(p=0.003); the percentage in 
social adaptation problems were 
17.3%, 6.8%, and 7.0%, 
respectively (p=0.000). 
Oerter, K., Manasco, P., Barnes, K.,  
Jones, J., Hill, S., & Cutler, G. 
(1991). Adult height in precocious 
puberty after long-term treatment 
with deslorelin. Journal of Clinical 
Endocrinology and Metabolism, 
73(6), 1235-1240. 
44 children (38 girls and 6 
boys) out of 161 who were the 
first to reach adult height in a 
long-term trial of deslorelin. 
Diagnosis of (Luteinizing 
hormone-releasing hormone) 
LNRH-dependent precocious 
puberty (as determined by 
response to LNRH) 
Longitudinal clinical trial study. 
Single non-randomized trial. 
Examined the relationship 
between early/precocious 
children’s predicted height and 
their final height after taking 
Deslorelin. 
Level 2 
At the start of treatment, the 
children had a mean bone age of 
11.8 ± 1.5 years prior to starting 
treatment. The mean adult height 
for the girls was 157.0  ± 5.9 cm 
(-1.1 ± 1.0 SD). The mean 
proximate adult height was 
significantly greater than the 
mean pretreatment predicted 
height (-1.1 ± 1.3 SD vs.  -2.0 ± 
1.3 SD, P<0.01), by 5.2  ± 8.4 
cm for the girls. The most recent 
predicted height was less than 
the predicted height at the end of 
treatment by 2.2 ± 4.0 cm 
(P<0.01). Proximate adult height 
inversely correlated with 
pretreatment bone age (r=-0.35, 
P=0.02). Basal luteinizing 
hormone levels decreased from 
8.7 ± 5.0 IU/L before the 
treatment to 3.1 ± 1.5 IU/L at the 
end of treatment (P<0.01). The 
peak LHRH-stimulated LH 
levels decreased from 76.3 ± 
53.1 IU/L before treatment to 
3.8 ± 2.3 IU/L at the end of 
treatment (P<0.01). Peak 
LHRH-stimulated FSH levels 
decreased from 24.8 ± 16.8 IU/L 
before treatment to 3.0 ± 1.5 
IU/L at the end of treatment 
(P<0.01). Estradiol levels in the 
girls were 243.7 ± 229.0 pmol/L 
before treatment and suppressed 
to 58.7 ± 18.4 pmol/L by the end 
of the treatment (P<0.01). After 
discontinuation of the 
medication, the mean ± SD 
growth was 5.1  ± 3.2, (r=0.34, 
P=0.025) and inversely with 
bone age (r=-0.53, P=0.0002).  
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Kauli, R., Galatzer, A., Kornreich, 
L., Lazar, L., Pertzelan, A., & Laron, 
Z. (1997). Final height of girls with 
central precocious puberty, untreated 
versus treated with cyproterone 
acetate or GnRH analogue. A 
comparative study with re-evaluation 
of predictions by the Bayley-Pinneau 
method. Hormone Res, 47(2), 54-61.  
102 girls with central 
precocious puberty.  
Cohort study. Of the 102 
participants, 26 were treated 
with Cyporterone Acetate 
(CyA), 48 were treated with 
GnRH analogue, and 28 were 
untreated.  
Examined the difference in final 
female height between who 
were treated with either CyA or 
GnRH or untreated.  
Level 2 
Their height was compared to 
the respective target height. 
Approximately half of the 
untreated girls had a slow course 
of puberty and reached THt +/- 
0.5 SD (FHt 160.2 +/- 7.1, THt 
159.5 +/- 6.6 cm); while the 
other half had an accelerated 
course of puberty with a FHt 
well below THt (FHt 150.8 +/- 
4.3, THt, 159.2 +/- 5.9 cm) and 
most were below the height-SDS 
of both parents. However, the 
treated girls (both medications) 
reached THt above (CyA group: 
FHt 157.8 +/- 5.1, THt 156.8 +/- 
5/1cm; GnRHA group: 159.6 +/- 
6.3, THt 157.7 +/- 5.7 cm). The 
results show that both that final 
height (FHt) is increased with 
either treatment (cytproterone or 
GnRH) regimens. Additionally, 
the optimal treatment should be 
started in girls younger than 12 
years due to a decreased bone 
age. 
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